当前位置: 首页 > 期刊 > 《中国现代医生》 > 202015
编号:13840555
不同同步放化疗方案治疗局部晚期食管鳞癌临床对比研究(4)
http://www.100md.com 2020年5月25日 《中国现代医生》 202015
     [13] Yu O,Saito Y,Kudo S,et al. The treatment results of definitive radiotherapy for cervical esophageal cancer:A single-institution experience[J]. Esophagus,2017,14(3):254-261.

    [14] Zhao L,Zhou Y,Mu Y,et al. Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer[J]. Oncotarget,2017,8(13):21852-21860.

    [15] Chen H,Wang H,Gu H,et al. Study for reducing lung dose of upper thoracic esophageal cancer radiotherapy by auto-planning:volumetric-modulated arc therapy vs intensity-modulated radiation therapy[J]. Med Dosim,2018, 43(3):243-250

    [16] Li X,Zhao J,Liu M,et al. Determination of radiotherapeutic target zones for thoracic esophageal squamous cell cancer with lower cervical lymph node metastasis according to CT-images[J]. Oncotarget,2016,7(24):35865-35873.

    [17] 王曉芬,吴珊珊,蔡艾芳,等.TP方案新辅助化疗治疗局部晚期食管癌的疗效观察[J].中国当代医药,2017,(17):57-59.

    [18] 王教辰,孔敏,陈保富,等.新辅助放化疗加手术治疗局部中晚期食管鳞癌的病理分析[J].中国现代医生,2014,(13):74-77.

    [19] 代新幼.三维适形超分割放疗治疗晚期食道鳞癌的疗效分析[J].中国医学创新,2012(16):121-122.

    [20] 谭章华,赵娇.紫杉醇联合奈达铂与奈达铂联合5-氟尿嘧啶作为一线方案治疗晚期食管鳞癌的对比研究[J].中国医药导报,2011,(26):96-97.

    (收稿日期:2019-10-15), 百拇医药(李道生)
上一页1 2 3 4